Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

Clinical trial NCT05710783 · COMPLETED

Trial details

NCT number: NCT05710783
Sponsor: Laboratorio Avi-Mex, S.A. de C.V.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2022-11-09
Primary completion: 2022-12-28
Enrollment: 4065

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.